Apyx Medical Corporation Provides Revenue Guidance for the Fourth Quarter and Full Year 2022
For the full year 2022, the company expected total revenue in a range of $44.0 to $44.4 million, representing a decline of 9% to 8% year-over-year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.38 USD | +3.76% |
|
0.00% | -47.33% |
May. 09 | Transcript : Apyx Medical Corporation, Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Stavros Vizirgianakis Enters into Letter Agreement with Apyx Medical | CI |
1st Jan change | Capi. | |
---|---|---|
-47.33% | 47.81M | |
-5.31% | 181B | |
-5.38% | 99.95B | |
-6.04% | 66.21B | |
+16.45% | 45.4B | |
-8.08% | 45.36B | |
+8.38% | 43.84B | |
+12.06% | 29.03B | |
+17.98% | 25.64B | |
-8.28% | 23.53B |